CD8A and neoplasm: On one hand, TAMs can inhibit migration of CD8+ T cells to the tumor, resulting in formation of an immune-excluded phenotype [20]; on the other hand, the cooperation of CTLs and macrophages is essential for tumor elimination after immunotherapy [21].